Reuters Health Report

Click to View in Browser 06/17/2014 Novartis, Pfizer seek U.S. approval of meningitis vaccines (Reuters) - Pfizer Inc and rival Swiss drugmaker Novartis AG on Tuesday said they had asked U.S. regulators to approve their vaccines to prevent meningitis infections in people aged 10 to 25. WHO says MERS virus of concern before haj, surge abating LONDON(Reuters) - The deadly MERS virus remains a serious public health problem, especially with the approach of haj pilgrimages, but a recent surge in Saudi cases of the respiratory disease appears to be abating, the World Health Organization said on Tuesday. GW Pharma hits high as cannabis drug helps fight epilepsy LONDON (Reuters) - An experimental cannabis drug has produced promising results in a small study of children with hard-to-treat epilepsy, sending shares in its British maker GW Pharmaceuticals to an all-time high. Ebola kills at least four in Liberia's capital DAKAR (Reuters) - At least four people have died from Ebola in Liberia's capital, a World Health Organization (WHO) and a government official said on Tuesday, the first confirmed deaths in Monrovia from a months-long regional outbreak. Wal-Mart China to raise food safety spending to $48 million BEIJING (Reuters) - The world's biggest retailer, Wal-Mart Stores Inc, said on Tuesday that it will increase its spending on food safety in China to 300 million yuan ($48.32 million) in 2013, 2014 and 2015, up from a previously-announced 100 million yuan in the same period. Many in U.S. push to share heroin overdose antidote with civilians QUINCY Mass. (Reuters) - Health worker Warren Nicoli got the call late one February night, from a Massachusetts dad who had just seen police revive his 19-year-old daughter from the death-like state of a severe heroin overdose. AbbVie all-oral hepatitis C therapy gets rapid EU review LONDON (Reuters) - European regulators have validated AbbVie's application for an experimental all-oral regimen for patients infected with the most common genotype of hepatitis C virus and the therapy is now under accelerated assessment. Merck KGaA terminates MS drug license agreement with Ono FRANKFURT (Reuters) - German drugmaker Merck KGaA agreed with Japan's Ono Pharmaceutical to terminate a license agreement over Ono's experimental multiple sclerosis (MS) drug ceralifimod. Staring at screens all day linked to changes in eye secretions NEW YORK (Reuters Health) – Office workers who spend long hours looking at computer screens have changes in their tear fluid similar to people with the disease known as dry eye, according to a study from Japan. Whooping cough reaches epidemic levels in California SAN FRANCISCO (Reuters) - Public health officials warn that whooping cough poses the greatest risk to young children as California deals with its worst outbreak of the respiratory disease since 2010, with nearly 3,500 reported victims so far this year. Related Video Twin tornadoes pummel U.S. state of Nebraska, killing one Twin tornadoes touch down in Nebraska The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend